Abstract Mycobacterial energy metabolism currently attracts strong attention as new target space for development of anti-tuberculosis drugs. The imidazopyridine Q203 targets the cytochrome bcc complex of the respiratory chain. a key component in energy metabolism. Q203 blocks growth of Mycobacterium tuberculosis at nanomolar concentrations. https://foldlyers.shop/product-category/chokes/